Definitive Contract HHSN261201300007C
Award Date
2/1/13
Potential Completion Date
2/7/24
Potential Value
$4.4M
Federal Agency
National Cancer Institute
Awardee
Mriglobal
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
B599 - Special Studies/Analysis- Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Kansas City, MO 64110, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $25,543,276.37 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the not-for-profit research organization Mriglobal (doing business as Midwest Research Institute). The contract is for the analysis of anti-cancer chemicals and pharmaceutical formulations. Mriglobal is a highly experienced federal contractor, holding several significant...
This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute to Mriglobal, a 501(c)(3) not-for-profit research organization based in Kansas City, Missouri. The contract, valued at $1,658,742.83, is for drug shelf life testing services. The contract does not have a set-aside designation. Mriglobal has significant experience as a prime contractor for the federal government, holding multiple Indefinite Delivery Vehicles (IDVs) with various agencies such as the National...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Mriglobal, doing business as Midwest Research Institute, a non-profit research organization. The contract is valued at $949,295.00 and will run through January 31, 2026. The contract is for the evaluation of the shelf-life of samples of investigational clinical drug formulations, including parenteral, oral, and other dosage...
This is a $26,932,208.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute, a civilian agency, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The contract is for a Centralized Chemopreventive Agent Repository and Chemistry Support and has an ultimate completion date of June 30, 2028. Mriglobal is the prime contractor and there is no set-aside designation indicated. The contract appears to be part of...
This federal contract award is for $17,180,292.00 and was made to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The contract is for biomedical management and support services, with a period of performance ending on July 31, 2007. It is a cost-plus-award-fee type contract, and there is no set-aside designation. Mriglobal specializes in areas such as medical countermeasure development, biosafety testing, threat detection technologies,...
This is a $5,108,214.00 cost-plus-award-fee delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to Mriglobal, a 501(c)(3) not-for-profit research organization also known as Midwest Research Institute. The contract is part of the Drug Manufacturing and Formulation Program (DMFP) indefinite delivery, indefinite quantity (IDIQ) contract. Mriglobal will perform the work in...
This is a federal task order award from the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Mriglobal, doing business as Midwest Research Institute, a non-profit research organization, with a total potential value of $3,754,601.88. The task order is for the Centralized Chemopreventive Agent Repository and Chemistry Support program, which involves maintaining a repository and distributing agents for cancer prevention studies. There is no...
This is a Cost Plus Award Fee delivery order under a $1,283,149.00 contract awarded by the National Institute of Neurological Disorders and Stroke, a civilian agency, to Mriglobal (also known as Midwest Research Institute), a 501(c)(3) not-for-profit research organization. The contract is part of the Drug Manufacturing and Formulation Program (DMFP) master IDIQ, and the task is for the PADERI HEAL PROJECT-IHP-102. There is no set-aside designation for this award. Mriglobal is the prime...
This is a $76,961,973.84 cost-plus-fixed-fee contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to the not-for-profit research organization MRIGlobal for "Chemistry Services for the NTP". The contract has an ultimate completion date of January 17, 2026 and was awarded on July 18, 2014 without a small business set-aside. MRIGlobal, doing business as Midwest Research Institute, is the prime contractor and has been awarded multiple...
This is a $19,091,009.00 cost-plus-fixed-fee definitive contract awarded by a U.S. government agency to the not-for-profit research organization Mriglobal, doing business as Midwest Research Institute. The contract, which has no set-aside designation, is for research and development work and is set to be completed by November 15, 2005. Mriglobal specializes in areas such as medical countermeasure development, biosafety testing, threat detection technologies, and specialized training programs,...